InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Life Sciences | Supplements

Year: 2010 2009 2008 2007


  • Editorial

    01 Oct 2010

  • Interview: How to manage an in-house IP team

    01 Oct 2010

    Sherry Knowles spent four years as chief patent counsel at GlaxoSmithKline after more than a decade in private practice. She tells Emma Barraclough what the experience taught her about working for pharmaceutical and biotech companies

  • Understand the economics behind licensing deals

    01 Oct 2010

    Companies in the life science sector are increasingly turning to licensing to boost their revenue streams. Richard Gering provides a guide to the deal structures they can use

  • Are patents for orphan drugs crucial?

    01 Oct 2010

    Richard Willoughby of Rouse considers whether patent protection remains important for orphan drugs

More from the Managing IP blog


null null null

nullnullnull

null

July /August 2019

AI and IP: the view from above

Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable



Most read articles

Supplements